The immune effects of neuropeptides

Bailliere's Clinical Rheumatology

Volumn 10, Issue 2, 1996, Pages 227-257

  Berczi, I ^a   Chalmers, I M ^a   Nagy, E ^a   Warrington, R J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ARGIPRESSIN; CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GONADOTROPIN; INSULIN; NERVE GROWTH FACTOR; NEUROPEPTIDE; OPIATE PEPTIDE; PROLACTIN; PROTIRELIN; SOMATOSTATIN; SUBSTANCE P; THYMUS EXTRACT; THYROTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIBODY RESPONSE; BONE MARROW; CELLULAR IMMUNITY; EMBRYO DEVELOPMENT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; NOMENCLATURE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; THYMUS;

EID: 0029973319     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(96)80016-1     Document Type: Article

References (241)

1. Aaronson SA (1991) Growth factors and cancer. Science 254:1146-1153.
2. Ader R, Telfen D & Cohen N (eds) (1991) Psychoneuroimmunology. New York: Academic Press.
3. Aebischer I, Stampfli MR, Zurcher A et al (1994) Neuropeptides are potent modulators of human in vitro immunoglobulin E synthesis. European Journal oflmmunology 24: 1908-1913.
4. Aloe L & Levi-Montalcini R (1977) Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Research 133: 358-366.
5. Amico-Roxas M, Caruso A, Leone MG et al (1989) Nerve growth factor inhibits some acute experimental inflammations. Archives of International Pharmacodynamics 299: 269-285.
6. Apte RN, Durum SK & Oppenheim JJ (1990) Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages. Immunology Letters 24: 141-148.
7. Arezzini C, De Gori V, Tarli P & Neff P (1972) Weight increase of body and lymphatic tissues in dwarf mice treated with human chorionic somatomammotropin (HCS). Proceedings of the Society for Experimental Biology and Medicine 141: 98-100.
8. Athreya BH, Pletcher J, Zulian F et al (1993) Subset specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro. Clinical Immunology and Immunopathology 66: 201-211.
9. Banks BEC, Vernon CA & Warner JA (1984) Nerve growth factor has anti-inflammatory activity in the rat hind paw oedema test. Neuroscience Letters 47: 41-45.
10. Baroni CD, Fabris N & Bertoli G (1969) Effects of hormones on development and function of lymphoid tissues. Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice. Immunology 17: 303-314.
11. Baroni CD, Pesando PC & Bertoli G (1971) Effects of hormones on development and function of lymphoid tissues. II. Delayed development of immunological capacity in pituitary dwarf mice. Immunology 21: 455-461.
12. Baxter ]B, Blalock JE & Weigent DA (1991) Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology 129:1727-1734.
13. Bellone G, Geuna M, Carbone Aet al (1995) Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells. Journal of Cellular Physiology 163: 221-231.
14. Berczi J (ed.) (1986) Pituitary Function and Immunity. Boca Raton, Florida: CRC Press.
15. Berczi I (1992) The immunology of prolactin. Seminars in Reproductive Endocrinology 10: 196-219.
16. Berczi I (1994) Hormonal interactions between the pituitary and immune system. In Grossman CJ (ed.) Bilateral Communication Between the Endocrine and Immune Systems, pp 96-144. Berlin:Springer.
17. Berczi I & Asa S (1996) Endocrine-immune interactions. In Kovacs K & Asa S (eds) Functional Endocrine Pathology 2rid edn. Boston: Blackwell Scientific Publications.
18. Berczi I & Kovacs K (eds) (1987) Hormones and Immunity. Lancaster, England: MTP Press.
19. Berczi I & Nagy E (1987) The effect of prolactin and growth hormone on hemolymphopoietic tissue and immune function. In Berczi I & Kovacs K (eds) Hormones and Immunity, pp 145-171. Lancaster: MTP Press Ltd.
20. Berczi I & Nagy E (1991) Human placental lactogen is a hemopoietic hormone. British Journal of Haematology 79: 355-358.
21. Berczi 1 & Nagy E (1994) Neurohormal control of cytokines during injury. In Rothwell NJ & Berkenbosch F (eds) Brain Control of Responses to Trauma. pp 32-107. Cambridge: Cambridge University Press.
22. Berczi I & Szelenyi J (eds) (1994) Advances in Psychoneuroimmunology. New York: Plenum Press.
23. Berczi I, Nagy E, Kovacs K & Horvath E (1981) Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinologica (Copenhagen) 98: 506-513.
24. Berczi I, Nagy E, Asa SL & Kovacs K (1983) Pituitary hormones and contact sensitivity in rats. Allergy 38: 325-330.
25. Berczi I, Nagy E, De Toledo SM et al (1991) Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. Journal of Immunology 146: 2201-2206.
26. van den Bergh P, Dobber R, Ramlal S et al (1994) Role of opioid peptides in the regulation of cytokine production by murine CD4+ T cells. Cellular Immunology 154: 109-122.
27. Berman JS & Center DM (1987) Chemotactic activity of porcine insulin for human T lymphocytes in vitro. Journal of Immunology 138: 2100-2103.
28. Bernton EW, Meltzer MT & Holaday JW (1988) Suppression of macrophage activation and Tlymphocyte function in hypoprolactinemic mice. Science 239: 401-404.
29. Besedovsky HO, del Rey A, Klusman Iet al (1991) Cytokines as modulators of the hypothalamuspituitary-adrenal axis. Journal of Steroid Biochemistry and Molecular Biology 40:613-618.
30. Bhat G, Gupta SK & Maiti BR (1983) Influence of prolactin on mitogenic activity of the bursa of Fabricius of the chick. General Comparative Endocrinology 52: 452-455.
31. Bischoff SC & Dahinden CA (1992) Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 79: 2662-2669.
32. Bohm A, Aloe L & Levi-Montalcini R (1986) Nerve growth factor enhances precocious differentiation and numerical increase in mast cells in cultures of rat splenocytes. Academia Nazionale dei Lincei 80: 1.
33. Bost KL, Clarke BL, Xu Jet al (1990) Modulation of IgM secretion and H chain mRNA expression in CH12.LX.C4.5F5 B cells by adrenocorticotropic hormone. Journal of Immunology 145:4326-433 l.
34. Boyle MDP, Lawman MJP, Gee AP & Young M (1985) Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. Journal oflmmunology 135: 564-568.
35. Brodie C & Gelfand EW (1992) Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. Journal oflmmunology 148: 3492-3497.
36. Cannon JG, Tatro JB, Reichlin S & Dinarello CA (1986) Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1. Journal of Immunology 337: 2232-2236.
37. Catania A & Lipton JM (1994) The neuropeptide alpha-melanocyte- stimulating hormone: a key component of neuroimmunomodulation. Neuroimmunomodulation 1: 93-99.
38. Cecilia-Fornari M, Femanda-Palacios M, Diez RA & Intebi AD (1994) Decreased chemotaxis of neutrophils in acromegaly and hyperprolactinemia. European Journal of Endocrinology 130: 463-t68.
39. Cesano A, Oberholtzer E, Contarini Met al (1994) Independant and synergistic effect of interleukin-2 and prolactin on development of T-and NK-derived LAK effectors, lmmunopharmacology 28:67-75.
40. Cesario TC, Yousefi S, Carandang Get al (1994) Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells. Proceedings of the Society of Experimental Biology and Medicine 205: 89-95.
41. Chiappelli F, Nguyen L, Bullington R & Fahey JL (1992) β-Endorphin blunts phosphatidylinositol formation during in vitro activation of isolated human lymphocytes: Preliminary report. Brain, Behavior and Immunity 6: 1-10.
42. Church MK, E1-Lati S & Caulfield JP (1991) Neuropeptide-induced secretion from human skin mast cells. International Archives of Allergy and Applied Immunology 94:310-318.
43. Clarke BL & Bost KL (1989) Differential expression of functional adrenocorticotropic hormone receptors by subpopulations of lymphocytes. Journal of Immunology 143: 464-469.
44. Clevenger CV, Sillman AL & Prystowsky MB (1990) Interleukin-2 driven nuclear translocation of prolactin in cloned T-lymphocytes. Endocrinology 127: 3151-3159.
45. Cohick WS & Clemmons DR (1993) The insulin-like growth factors. Annual Review of Physiology 55: 131-153.
46. Cook GA, Elliott D, Metwali A et al (1994) Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor. The Journal of Immunology 152: 1830-1835.
47. Cosson C, Myara I, Guillemain R et al (1989) Serum prolactin as a rejection marker in heart transplantation. Clinical Chemistry 35: 492.
48. Coutelier JP, Kehrl JH, Bellur SS et al (1990) Binding and functional effects of thyroid stimulating hormone on human immune cells. Journal of Clinical Immunology 10: 204-210.
49. Crafts RC & Meinecke HA (1959) The anemia of hypophysectomized animals. Annals of the New York Academy of Science 77: 501-517.
50. Crilly PJ, Johnson PC, Gardner MJ & Flint DJ (1994) Immunoneutralisation of GH in neonatal rats results in defects in lymphatic tissues and the humoral immune response. Endocrine Journal 2:105-109.
51. Crist DM & Kraner JC (1990) Supplemental growth hormone increases the tumor cytotoxic activity of natural killer cells in healthy adults with normal growth hormone secretion. Metabolism 39:1320-1324.
52. Crist DM, Peake GT, Mackinnon LT et al (1987) Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion. Metabolism 36:1115-1117.
53. Cross R J, Campbell JL, Markesbery WR & Roszman TL (1990) Transplantation of pituitary grafts fail to restore immune function and to reconstitute the thymus glands of aged mice. Mechanisms of Ageing and Development 56:11-22.
54. Damonneville M, Monte D, Auriault C & Capron A (1990) The neuropeptide substance-P stimulates the effector functions of platelets. Clinical Experimental Immunology 81: 346-351.
55. Dardenne M, Itoh T & Homo-Delarche F (1986) Presence of glucocorticoid receptors in cultured thymic epithelial cells. Cellular Immunology 100:112-118.
56. Denko CW & Gabriel P (1985) Effect of peptide hormones in urate crystal inflammation. Journal of Rheumatology 12: 971-975.
57. DeRose V, Robbins SA, Snider RM et al (1994) Substance P increases neutrophil adhesion to bronchial epithelial cells. The Journal of Immunology 152: 1339-1346.
58. DiMattia GE, Gellersen B, Bohnet HG & Friesen HG (1988) A human B-lymphoblastoid cell line produces prolactin. Endocrinology 122: 2508-2517.
59. DiMattia GE, Gellersen B, Duckworth ML & Friesen HG (1990) Human prolactin gene expression:the use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblastoid cell line. Journal of Biological Chemistry 265: 16412-16421.
60. Dougherty TF (1952) Effect of hormones on lymphatic tissue. Physiology Review 32: 379-407.
61. Duckworth ML, Robertson MC, Schroedter IC et al (1993) Molecular genetics and biology of the rat placental prolactin family. In Soares MJ, Handwerger S & Talamantes F (eds) Trophoblast Cells: Pathways for Maternal-Embryonic Communication, pp 169-190. New York: Springer.
62. Edwards CK, Ghiasuddin SM, Yunger LM et al (1992) In vivo administration of recombinant growth hormone or gamma-interferon activates macrophages-Enhanced resistance to experimental Salmonella-typhimurium infection is correlated with generation of reactive oxygen intermediates. Infection and Immunity 60: 2514-2521.
63. Elsasser TH, Fayer R, Rumsey TS & Hartnell GF (1994) Recombinant bovine somatotropin blunts plasma tumor necrosis factor-alpha, cortisol, and thromboxane-B2 responses to endotoxin in vivo. Endocrinology 134: 1082-1088.
64. Esquifino AI, Villanua MA, Szary A et al (1991) Ectopic pituitary transplants restore immunocompetence in Ames dwarf mice. Acta Endocrinologica 125: 67-72.
65. Fabris N, Jankovic BD, Markovic BM & Spector NH (eds) (1992) Ontogenic and phylogenetic mechanisms of neuroimmunomodulation. Annals of the New York Academy of Science 650.
66. Foreman JC (1987) Neuropeptides and the pathogenesis of allergy. Allergy 42:1-11.
67. Foils G, Gyimesi E & Komaromi I (1985) The mechanism of antibody-dependent cellular cytotoxicity stimulation by somatostatin in rat peritoneal macrophages. Cellular Immunology 90:217-225.
68. Fornari MC, Scolnik MP, Palacios MF et al (1994) Growth hormone inhibits normal B-cell differentiation and neutrophils' chemotaxis in vitro. International Journal of Immunopharmacology 16:667-673.
69. Fraenkel-Conrat H & Li CH (1949) Normal effects on the nucleic acid and phospholipid turnover of rat liver and thymus. Endocrinology 44:487-491.
70. Franklin RA, Brodie C, Melamed I et al (1995) Nerve growth factor induces activation of MAPkinase and p90rsk in human B lymphocytes. Journal of Immunology 154: 4965-4972.
71. Fu YK, Arkins S, Li YM et al (1994) Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone. Infection and Immunity 62: 1-8.
72. Gagneranlt MC, Touraine P, Savino Wet al (1993) Expression of prolactin receptors in marine lymphoid cells in normal and autoimmune situations. Journal of Immunology 150: 5673-5681.
73. Gala RR & Shevach EM (1993) Influence of prolactin and growth hormone on the activation of dwarf mouse lymphocytes in vivo. Proceedings of the Society for Experimental Biology and Medicine 204: 224-230.
74. Gaytan F, Romero JL, Bellido C et al (1994) Effects of growth hormone and prolactin on testicular macrophages in long-term hypophysectomized rats. Journal of Reproductive Immunology 27:73-84.
75. Gee AP, Boyle MDP, Munger KL et al (1983) Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proceedings of the National Academy of Sciences, USA 80: 7213-7218.
76. Geffner ME, Bersch N, Lippe BM et al (1990) Growth hormone mediates the growth of Tlymphoblast cell lines via locally generated insulin-like growth factor-I. Journal of Clinical Endocrinology and Metabolism 71: 464-469.
77. Gellersen B, DiMattia GE, Friesen HG & Bohnet HG (1989a) Regulations of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion. Endocrinology 125: 2853-2861.
78. Gellersen B, DiMattia GE, Friesen HG & Bohnet HG (1989b) Prolactin (PRL) mRNA from human decidua differs from pituitary PRL mRNA but resembles the IM-9-P3 lymphoblast PRL transcript. Molecular and Cellular Endocrinology 64: 127-130.
79. GeUersen B, Kempf R, Telgmann R & DiMattia GE (1994) Nonpituitary human prolaetin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial strorna. Molecular Endocrinology 8: 356-373.
80. Gilmore W & Weiner LP (1988) β-Endorphin enhances interleukin-2 (IL-2) production in marine lymphocytes. Journal of Neuroimmunology 18: 125-138.
81. Glyn-Ballinger JR, Bernardini GL & Lipton JM (1983) Alpha-MSH injected into the septal region reduces fever in rabbits. Peptides (Fayetteville) 4: 199.
82. Goelst K, Mitchell D & Laburn H (1991) Effects of ct-melanocyte stimulating hormone on fever caused by endotoxin in rabbits. Journal of Physiology 441: 469-476.
83. Goetzl EJ (ed.) (1985) Proceedings of a conference on neuromodulation of immunity and hypersensitivity. Journal of Immunology 135.
84. Grossman CJ (ed.) (1994) Bilateral Communication Between the Endocrine and Immune Systems. New York: Springer-Verlag.
85. Guillemin R, Cohn M & Melnechuk T (eds) (1985) Neural Modulation of Immunity. New York:Raven Press.
86. Hadden JW, Galy A, Chen H & Hadden EM (1989) A pituitary factor induces thymic epithelial cell proliferation in vitro. Brain, Behaviour and Immunity 3" 149-159.
87. Hammar JA (1921) The new views as to the morphology of the thymus gland and their bearing on the problem of the function of the thymus. Endocrinology 5: 543-573, 731-760.
88. Harbour DV, Leon S, Keating C & Hughes K (1990) Thyrotropin modulates B-cell function through specific bioactive receptors. Progress in Neuroendocrinimmunology 3: 266-276.
89. Hartmann DP, Holaday JW & Bernton DW (1989) Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB Journal 3: 2194-2202.
90. Hartung HP, Heininger K, Schafer B & Toyka KV (1988) Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism. Federation of American Society of Experimental Biology Journal 2: 48-51.
91. Hatfill SJ, Kirby R, Hanley Met al (1990) Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression of human prolactin in blast cells of a patient of subtype M4. Leukemia Research 14: 57-62.
92. Hayashida T & Li C-H (1957) Influence of adrenocorticotropic and growth hormone on antibody formation. Journal of Experimental Medicine 105: 93.
93. Heijnen CJ, Zijlstra J, Kavelaars A et al (1987) Modulation of the immune response by POMCderived peptides. I. Influence on proliferation of human lymphocytes. Brain, Behavior and Immunity 1:284-291.
94. Helderman JH & Strom TB (1978) Specific insulin binding site on T and B lymphocytes as a marker of cell activation. Nature 274: 62-63.
95. Hench PS, Kendall EC, Slocumb CH & Polley HF (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-ll-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proceedings of Staff Meetings Mayo Clinic 24:181-197.
96. Hiestand PC, Gale JM & Melker P (1986a) Soft immunosuppression by inhibition of prolactin release: synergism with cyclosporine in kidney allograft survival and in the localized graftversus-host reaction. Transplant Proceedings 18: 870-872.
97. Hiestand PC, Melker P, Nordmann R, Grieder A & Permongkol C (1986b) Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proceedings of the National Academy of Sciences USA 83: 2599-2603.
98. Hiddinga HJ, Isaak DD & Lewis RV (1994) Enkephalin-containing peptides processed from proenkephalin significantly enhance the antibody-forming cell responses to antigens. Journal of Immunology 152: 3748-3759.
99. Hiltz ME & Lipton JM (1989) Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide ~-MSH. FASEB Journal 3: 2282-2284.
100. Hoghe-Peters EL & Hoghe R (1995) Growth Hormone, Prolactin and IGF-I as Lymphohemopoietic Cytokines. Austin: RG Landes Co.
101. Hokfelt T, Elde R, Johansson Oet al (1976) lmmunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience 1: 131-136.
102. Horseman ND (1994) Editorial: Famine to feast-growth hormone and prolactin signal transducers. Endocrinology 135: 1289-1291.
103. Horseman ND & Yu-Lee LY (1994) Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocrine Reviews 15: 627-649.
104. Iwamoto I, Tomoe S, Tomioka H & Yoshida S (1993) Leukotriene B 4 mediates substance P-induced granulocyte infiltration into mouse skin. The Journal of Immunology 151: 2116-2123.
105. Jain R, Don Zwickler, Hollander CS et al (1991 ) Corticotropin-releasing factor modulates the immune response to stress in the rat. Endocrinology 128: 1329-1335.
106. Jancso N, Jancso-Gabor A & Szolcsanyi J (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. British Journal of Pharmacology 31: 138-151.
107. Jancso G, Obal F Jr, Toth-Kasa Iet al (1985) The modulation of cutaneous inflammatory reactions by peptide-containing sensory nerves. International Journal of Tissue Reactions 7: 449-457.
108. Jankovic BD, Markovic BM & Specter NH (eds) (1987) Neuroimmune Interactions: Proceedings of the Second International Workshop on Neuroimmunomodulation. New York: New York Academy of Science.
109. Jardieu P, Clark R, Mortensen D & Dorshkind K (1994) In rive administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. Journal of Immunology 152: 4320-4327.
110. Jepson JH & Lowenstein L (1967) The effect of testosterone, adrenal steroids, and prolactin on erythropoiesis. Acta Haematologica 38: 292-299
111. Jessop DS, Jukes KE & Lightman SL (1994) Release of alpha-melanocyte-stimulating hormone from rat splenocytes in vitro is dependent on protein synthesis. Immunology Letters 41: 191-194.
112. Jeurissen F, Kavelaars A, Korstjens Met al (1994) Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase. Journal of Immunology 152: 2987-2994.
113. Kannan Y, Ushio H, Koyama H et at (1991) Nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood 77: 1320-1325.
114. Kaplan SL, Grmnbach MM, Friesen HG & Costom BH (1972) Thyrotropin-releasing factor (TRF) effect on secretion of human pituitary prolactin and thyrotropin in children and in idiopathic hypopitnitary dwarfism: further evidence for hypophysiotropic hormone deficiencies. Journal of Clinical Endocrinology and Metabolism 35: 825-830.
115. Karalis K, Sane H, Redwine ]et al (1991) Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254: 421-423.
116. Kassessinoff TA & Pearce FL (1988) Histamine secretion from mast cells stimulated with somatostatin. Agents and Actions 23:211-213.
117. Kavelaars A, Ballieux RE & Heijnen C (1988) Modulation of the immune response by proopiomelanocortin derived peptides. II. Influence of adrenocorticotropin hormone on the rise in intracellular free calcium concentration after T-cell activation. Brain, Behavior and Immunity 2:57-66.
118. Kelley DM, Lichtenstein A, Wang Jet al (1994) Corticotropin-releasing factor reduces lipopo/ysaccharide-induced pulmonary vascular leak. Immunopharmacology and lmmunotoxicology 16:139-t48.
119. Kelley KW, Arkins S & Li YM (1992) Growth hormone, prolaetin, and insulin-like growth factors: New jobs for old players. Brain, Behaviour and Immunity 6: 317-326.
120. Kelley KW, Brief S, Westly HJ et al (1986) GH 3 pituitary adenoma cells can reverse thymic aging in rats. Proceedings of the National Academy of Sciences USA 83: 5663-5667.
121. Kelly PA, Djiane J, Postel-Vinay MC & Edery M (1991) The prolactin/growth hormone receptor family. Endocrine Reviews 12: 235-251.
122. Kimata H & Fujimoto M (1994a) Growth hormone and insulin-like growth factor I induce immunoglobulin (lg)E and lgG4 production by human B cells. Journal of Experimental Medicine 180" 727-732.
123. Kimata H & Fujimoto M (1994b) Vasoactive intestinal peptide specifically induces human IgA1 and lgA2 production. European Journal of Immunology 24: 2262-2265.
124. Kimata H & Yoshida A (1994) Effect of growth hormone and insulin-like growth factor-I on immunoglobulin production by and growth of human B cells. Journal of Clinical Endocrinology and Metabolism 78: 635-641.
125. Kimata H, Yoshida A, Ishioka C et al (199t) Nerve growth factor specifically induces human lgG4 production, European Journal of Immunology 21: 137-141.
126. Kishimoto T, Taga T & Akira S (1994) Cytokine signal transduction. Cell 76: 253-262.
127. Koh CY & Phillips JT (1993) Prolactin receptor expression by lymphoid tissues in normal and immunized rats. Molecular and Cellular Endocrinology" 92: R21-R25.
128. Komorowski J & Stepien H (1994) FSH and LH induce interleukin-6 (IL-6) release from human peripheral blood monocytes cultures in vitro. A dose-response study. Hormone and Metabolic Research 26: 438-439.
129. Komorowski J, Zylinska K, Pawlikowski M & Stepien H (1993) Stimulatory effect of thyrotropin (TSH) on interleukin-2 (IL-2) release from human peripheral blood lymphocytes. A doseresponse study in vitro. Hormones and Metabolic Research 25: 598-599.
130. Komorowski J, Stepien H & Pawlikowski M (1994) Increased interleukin-2 levels during standard TRH test in man. Neuropeptides 27: 151-156.
131. LeBoeuf RD, Burns JN, Best KL & Blalock JE (1990a) Isolation, purification, and partial character ization of suppressin, a novel inhibitor of cell proliferation. Journal of Biological Chemistry 265:158-165.
132. LeBoeuf RD, Carr DJJ, Green MM & BIalock JE (1990b) Cellular effects of suppressin: A biological response modifier of cells of the immune system. Progress in Neuroendocrinimmunology 3:176-187.
133. Levi-Montaleini R 0966) The nerve growth factor, its mode of action on sensory and sympathetic nerve ceils. Harvey Lectures 60: 217-259.
134. Lewis UJ (1992) Growth hormone-What is it and what does it do. Trends in Endocrinology and Metabolism 3: 117-121.
135. Lipton JM (1988) α-MSH in CNS control of fever and its influence on inflammation/immune responses. In Hadley ME (ed.) The Melanotropic Peptides, vol. 2, pp 97-113. Boca Raton: CRC Press.
136. Lobie PE, Mertani H, Morel Get al (1994) Receptor-mediated nuclear translocafion of growth hormone. Journal of Biological Chemistry 269: 21330-21339.
137. Lotz M, Carson DA & Vaughan JH (1987) Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis. Science 235: 893-895.
138. Luber-Narod J, Kage R & Leeman SE (1994) Substance P enhances the secretion of tumor necrosis factor-alpha from neuroglial cells stimulated with lipopolysaccharide. Journal of Immunology 152: 819-824.
139. Lundhlad L, Lundberg JM, Anggard A & Zetterstrom D (1987) Capsaicin-sensitive nerves and the cutaneous allergy reaction in man. Possible involvement of sensory neuropeptides in the flare reaction. Allergy 42: 20-25.
140. Macaluso A, McCoy D, Ceriani Get al (1994) Antiinflanamatory influences of α-MSH molecules:central neurogenic and peripheral actions. Journal of Neuroscience 14: 2377-2382.
141. Malkinson T J, Bridges TE, Lederis K & Veale WL (1987) Perfusion of the septum of the rabbit with vasopressin antiserum enhances endotoxin feven Peptides 8: 385-389.
142. Manfredi R, Tumietto F, Azzaroli Let al (1994) Growth hormone (GH) and the immune system: impaired phagocytic function in children with idiopathic GH deficiency is corrected by treatment with biosynthetic GH. Journal of Pediatric Endocrinology 7: 245-251.
143. Manning PT, Russell JH, Simmons B & Johnson EM (1985) Protection from guanethidine-induced neuronal destruction by nerve growth factor: effect of NGF on immune function. Brain Research 340: 61-69.
144. Marshall JS, Stead RH, McSharry C et al (1990) The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor. Journal of Immunology 144: 1886-1892.
145. Matera L, Cesano A, Muccioli G & Veglia F (1990) Modulatory effect Of prolactin on the DNA synthesis rate and NK activity of large granular lympbocytes. International Journal of Neuroscience 51: 265-267.
146. Matera L, Cesano A, Bellone G & Oberholtzer E (1992) Modulatory effect of prolactin on the resting and mitogen-iuduced activity ofT, B, and NK tymphocytes. Brain, Behaviour, and Immunity 6:409-417.
147. Mazorow DL, Simpkins CO & Millar DB (1994) Beta-endorphin modulates calcium channel activity in human neutrophils. Journal of Neuroimmunology 50: 77-83.
148. McGillis JP, Organist ML & Payan DG (1987) Substance P and immunoregulation. Federation Proceedings 46: 196-199.
149. McKay DM & Bienenstock J (1994) The interaction between mast cells and nerves in the gastrointestinal tract. Immunology Today 15: 533-538.
150. Merchav S, Tatarsky I & Hochberg Z (1988a) Enhancement of human grannlopoiesis in vitro by biosynthetic insulin-like growth factor Usomatomedin C and human growth hormone. Journal of Clinical Investigation 81:791-797.
151. Merchav S, Tatarsky I & Hochberg Z (1988b) Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin like growth factor-I. British Journal of Haematology 70: 267-27.
152. Merimee TJ, Grant MB, Broder CM et al (1989) Insulin-like growth factor secretion by human Blymphocytes: a comparison of cells from normal and pygmy subjects. Journal of Clinical Endocrinology and Metabolism 69: 978-984.
153. Millar DB, Hough CJ, Mazorow DL & Gootenberg JE (1990) β-Endorphin's modulation of lymphocyte proliferation is dose, donor, and time dependent. Brain, Behavior and lmmunity 4:232-242.
154. Montgomery DW, Zukoski CF, Shah GH et al (1987) Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immnnoreactivity. Biochemistry and Biophysics Research Communications 145: 692-698.
155. Montgomery DW, LeFevre JA, Ulrich ED et al (1990) Identification of prolactin-like proteins synthesized by normal murine lymphocytes. Endocrinology 127: 2601-2603.
156. Montgomery DW, Shen GK, Ulrich ED et al (1992) Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology 131:3019-3026.
157. Moreno J, Vicente A, Heijnen I & Zapata AG (1994) Prolactin and early T-cell development in embryonic chicken. Immunology Today 15: 524-526.
158. Murphy MT, Richards DB & Lipton JM (1983) Antipyretic potency of centrally administered alphamelanocyte stimulating hormone. Science 221: 192-193.
159. Murphy WJ, Durum SK, Anver MR & Longo DL (1992) Immunologic and hematologic effects of neuroendocrine hormones. Journal of Immunology 148: 3799-3805.
160. Muscettola M & Grasso G (1990) Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells, lmmunobiology 180:419-430.
161. Nagy E & Berczi I (1978) Immunodeficiency in hypophysectomized rats. Acta Endocrinologica 89:530-537.
162. Nagy E & Berczi I (1989) Pituitary dependence of bone marrow function. British Journal of Haematology 71: 457-462.
163. Nagy E, Berczi I & Friesen HG (1983) Regulation of immunity in rats by lactogenic and growth hormones. Aeta Endocrinologica 102: 351-357.
164. Nagy E, Berczi I, Wren GE et al (1983) Immunomodnlation by bromocriptine, lmmunopharmacology 6:231-243.
165. Nawa H, Kotani H & Nakanishi S (1984) Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature 312: 729-734.
166. Nickel BE, Kardami E & Cattini PA (1990) The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells. Endocrinology 126:971-976.
167. Nicoll CS (1982) Prolactin and growth hormone: Specialists on one hand and mutual mimics on the other. Perspectives in Biological Medicine 25: 369-381.
168. Nicoll CS, Herbert NJ, Delidow BC et al (1990) Prolactin and synlactin: Comparative aspects. Progress in Clinical Biological Research 342:211-218.
169. Nong YH, Titus RG, Ribeiro JMC & Remold HG (1989) Peptides encoded by the calcitonin gene inhibit macrophage function. Journal of Immunology 145: 45-49.
170. Oates EL, AUaway GP, Armstrong GR et al (1988) Human lymphocytes produce pro-opiomelanocortin-related gene transcripts. Journal of Biological Chemistry 263:10 041-10 044.
171. O'Dorisio MS (1986) Neuropeptides and gastrointestinal immunity. American Journal of Medicine 81: 74-82.
172. O'Dorisio MS (1987) Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous endocrine and immune systems. Federation Proceedings 46: 192-195.
173. Olsen N J, Nicholson WE, DeBold CR & Orth DN (1992) Lymphocyte derived adrenocorticotropin is insufficient to stimulate adrenal steroidogenesis in hypophysectomized rats. Endocrinology 130:2113-2119.
174. Ottaway CA (1984) In vitro alterations of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T ceils. Journal of Experimental Medicine 160: 1054-1069.
175. Ottaway CA & Husband AJ (1994) The influence of neuroendocrine pathways on lymphocyte migration. Immunology Today 15:511-517.
176. Otten U, Ehrhard P & Peck R (1989) Nerve growth factor induces growth and differentiation of human B lymphocytes. Proceedings of the National Academy of Sciences, USA 86: 10059-10 063.
177. Pandian MR & Talwar GP (197l) Effect of growth hormone on the metabolism of thymus and on the immune response against sheep erythrocytes. Journal of Experimental Medicine 134: 1095-1113.
178. Payan DG, McGillis JP, Renold FK et al (1987) The immunomodulating properties of neuropeptides. In Berczi I & Kovacs K (eds) Hormones and Immunity. Lancaster, England: MTP Press.
179. Pearce FL & Thompson HL (1986) Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. Journal of Physiology 372: 379-393.
180. Pezzati P, Stanisz AM, Marshall JS et al (1992) Expression of nerve growth factor receptor immunoreactivity on follicular dendritic cells from human mucosa associated lymphoid tissues. Immunology 76: 485-490.
181. Plotnikoff NP, Faith RE, Murgo AJ & Good RA (eds) (1986) Enkephalins and Endorphins: Stress and the Immune System. New York: Plenum Press.
182. Potter EL & Craig JM (1975) Pathology of the Fetus and the Infant, 3rd edn. Chicago: Year Book.
183. Rajakulasingam K (1994) Neural control of rhinitis. Clinical Experimental Allergy 24: 897-898.
184. Rameshwar P, Ganea D & Gascon P (1994) Induction of 1L-3 and granulocyte-macrophage colonystimulating factor by substance P in bone marrow cell is partially mediated through the release of IL-1 and IL-6. The Journal of Immunology 152:40-4 49
185. Ramos-Zepeda R, Kretschmer K, Lopez-Osuna M et al (1973) Evaluacion de la funcion immunologica en el hipopitnitarismo humano. Archives de lnvestigaciones Medicales (Mexico) 4:197-206.
186. Rao YP, Olson MD, Buckley DJ & Buckley AR (1990) Nuclear co-localization of prolactin and the prolactin receptor in rat Nb2 node lymphoma cells. Endocrinology 133: 3062-3065.
187. Rapaport R, Oleske J, Ahdieh H et al (1986) Suppression of immune function in growth hormone deficient children during treatment with human growth hormone. Journal of Pediatrics 109: 434-439.
188. Rapaport R, Oleske J, Ahdieh H et al (1987) Effects of human growth hormone on immune functions: In vitro studies on cells of normal and growth hormone-deficient children. Life Sciences 41:2319-2324.
189. Robertson B, Dostal K & Daynes RA (1988) Neuropeptide regulation of inflammatory and immunologic responses. The capacity of α-melanocyte- stimulating hormone to inhibit tumor necrosis factor and IL-l-inducible biologic responses. Journal oflmmunology 140: 4300-4307.
190. Rongen-Westerlaken C, Rijkers GT, Scholtens EJ et al (1991) Immunologic studies in Turner syndrome before and during treatment with growth hormone. Journal of Pediatrics 119:268-272.
191. Rothwell NJ & Berkenbosch F (eds) (1994) Brain Control of Responses to Trauma. Cambridge: Cambridge University Press.
192. Rouabhia M, Chakir J & Deschaux P (1991) Interaction between the immune and endocrine systems: lmmunodulatory effects of luteinizing hormone. Progress in Neuroendocrinimmunology 4:86-91.
193. Rovensky J, Ferencikova J, Vigas M et al (1985) Effect of growth hormone on the activity of some lysosomal enzymes in neutrophilic polymorphonuclear leukocytes of hypopituitary dwarfs. International Journal of Tissue Reactions 7: 153-159.
194. Rui H, Lebrun J J, Kirken RA et al (1994) JAK2 activation and cell proliferation induced by antibodymediated prolactin receptor dimerization. Endocrinology 135: 1299-1306.
195. Russell DH, Mills KT, Talamantes RJ & Bern HA (1988) Neonatal administration of prolactin antiserum alters the developmental pattern of T-and B-lymphocytes in the thymus and spleen of BALB/c female mice. Proceedings of the National Academy of Sciences USA 85: 7404-7407.
196. Savino W, Mello-Coelho V & Dardenne M (1994) Neuroendocrine control of the thymic microenvironment:role of pituitary hormones. In Berczi I & Szelenyi J (eds) Advances in Psychoneuroimmunology, pp 75-82. New York: Plenum Press.
197. Schauer E, Trautinger F, Kock Aet al (1994) Proopiomelanocortin-derived peptides are synthesized and released by human keratinoeytes. Journal of Clinical Investigation 93: 2258-2262.
198. Serra M, Bazzoni F, Della Bianca Vet al (1988) Activation of human neutrophils by substance P. Effect on oxidative metabolism, exocytosis, cytosolic Ca2+ concentration and inositol phosphate formation. Journal of lmmunology 141:2118-2124.
199. Selye H (1936a) Thymus and adrenals in the response of the organism to injuries and intoxications. British Journal of Experimental Pathology 17: 234-248.
200. Selye H (1936b) A syndrome produced by diverse nocuous agents. Nature 138: 32.
201. Selye H (1942) The pharmacology of steroid hormones and their derivatives. Review of Canadian Biology 1: 577432.
202. Shanahan F, Lee TDG, Bienenstock J & Befus AD (1986) Mast cell heterogeneity: Effect of antiallergic compounds on neuropeptide-induced histamine release, lnternationl Archives of Allergy and Applied Immunology 80: 424-426.
203. Shen GK, Montgomery DW, Ulrich ED et al (1992) Upregulation of prolactin gene expression and feedback modulation of lymphocyte proliferation during acute allograft rejection. Surgery 112:387-393.
204. Singh U & Owen JJT (1976) Studies on the maturation of thymus stem cells. The effects of catecholamines, histamine and peptide hormones on the expression of T cell alloantigens. European Journal of Immunology 6: 59-62.
205. Skwarlo-Sonta K, Sotowaska-Brochocka J, Rosolowska-Huszcz D et al (1987) Effect of prolactin on the diurnal changes in immune parameters and plasma corticosterone in white leghorn chickens. Acta Endocrinologiea 116: 172-178.
206. Smith PE (1930) Effect of hypophysectomy upon the involution of the thymus in the rat. Anatatomical Record 47:119-129.
207. Smith EM, Brosnan P, Meyer WJ & Blalock JE (1987) An ACTH receptor on human mononuclear leukocytes: relation to adrenal ACTH-receptor activity. New England Journal of Medicine 317:1266-1269.
208. Smith EM, Hughes TK, Cadet P & Stefano GB (1992) Corticotropin- releasing factor-induced immunosuppression in human and invertebrate immunocytes. Cellular and Molecular Neurobiology 12: 473-481.
209. Sotowaska-Brochocka J, Rosolowska-Hnszcz D, Skwarlo-Sonta K & Gajewska A (1984) Effect of exogenous prolactin on immunity in chickens. Research in Veterinary Science 37: 123-125.
210. Southard JN & Talamantes F (1991) Placental prolactin-like proteins in rodents-Variations on a structural theme. Moleclar and Cellular Endocrinology 79: C133-140
211. Spangelo BL, Hall NRS, Ross PC & Goldstein AL (1987) Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin, lmmunopharmacology 14:11-20.
212. Stamenkovic I, Clark EA & Seed B (1989) A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO Journal 8: 1403-1410.
213. Stead RH, Perdue MH, Cooke H et al (eds) (1992) Neuro-immuno-physiology of the gastrointestinal mucosa. Implications for inflammatory diseases. Annals of the New York Academy of Science 664.
214. Stefano GB (1989) Role of opioid neuropeptides in immunoregulation. Progress in Neurobiology 33: 149-159.
215. Sundar SK, Becker KJ, Cierpial MA et al (1989) Intracerebro-ventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proceedings of the National Academy of Sciences, USA 86: 6398-6402.
216. Taub DD, Tsarfaty G, LLoyd AR et al (1994) Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. Journal of Clinical Investigation 94: 293-300.
217. Taylor AW, Streilein JW & Cousins SW (1994a) Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. Journal of Immunology 153: 1080-1086.
218. Taylor AW, Streilein JW & Cousins SW (1994b) Alpha-melanocyte- stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1: 188-194.
219. Thorpe LW & Perez-Polo JR (1987) The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. Journal of Neuroscience Research 18: 134-139.
220. Timsit J, Savino W, Safieh B et al (1992) Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. Journal of Clinical Endocrinology and Metabolism 75: 183-188.
221. Todd I, Pujol-Borrell R, Hammond LJ et al (1987) Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone. Clinical Experimental Immunology 69: 524-531.
222. Tortes BA & Johnson HW (1988) Arginine vasopressin (AVP) replacement of helper cell requirement in IFN-T production. Evidence for a novel AVP receptor on mouse lymphocytes. Journal of Immunology 140: 2179-2183.
223. Touraine P, Leite de Moraes MC, Dardenne M & Kelly PA (1994) Expression of short and long forms of prolactin receptor in murine lymphoid tissues. Molecular and Cellular Endocrinology 104:183-190.
224. Tsagarakis S & Grossman A (1994) Corticotropin-releasing hormone: interactions with the immune system. Neuroimmunomodulation 1: 329-334.
225. Tyden G, Berg U & Reinholt F (1990) Acute renal graft rejection after treatment with human growth hormone. Lancet 336: 1455-1456.
226. Vamvakopoulos NC & Chrousos GP (1994) Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. Endocrine Review 15: 409-420.
227. Wang J & Klein JR (1994) Thymus-neuroendocrine interactions in extrathymic T cell development. Science 265: 1860-1862.
228. Wang X, Fiscus RR, Tang Z et al (1994) CGRP in the serum of endotoxin-treated rats suppresses lymphoproliferation. Brain, Behavior, and Immunity 8: 282-292.
229. Warwick-Davies J, Lowrie DB & Cole PJ (1995) Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release of H2O2. Journal of Immunology 154: 1909-1918.
230. Weber RJ & Pert A (1989) The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245: 188-190.
231. Weigent D & Blalock JE (1994) Effect of the administration of growth-hormone-producing lymphoeytes on weight gain and immune function in dwarf mice. Neuroimmunomodulation 1: 50-58.
232. Wells JA & de Vos AM (1993) Structure and function of human growth hormone: implications for the hematopoietins. Annual Review of Biophysical and Biomolecular Structures 22:329-351.
233. Wiedermann C J, Niedermuhlbicher M, Geissler D et al (1991) Priming of normal human neutrophils by recombinant human growth hormone. British Journal of Haematology 78: 19-22.
234. Wiedermann C J, Reinisch N & Braunsteiner H (1993) Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. Blood 82: 954-960.
235. Wilner ML, Ettenger RB, Koyle MA & Rosenthal JT (1990) The effect of hypoprolactinemia alone and in combination with cyclosporine on allograft rejection. Transplantation 49: 264-267.
236. Xin Z, Tang H & Ganea D (1994) Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. Journal of Neuroimmunology 54: 59-68.
237. Yakar S, Domene H, Meidan R et al (1994) Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-binding protein (IGFBP)-2 gene expression in spleens of juvenile rats. Hormones and Metabolism Research 26: 363-366.
238. Yamada M, Hato F, Kinoshita Y et al (1994) The indirect participation of growth hormone in the thymocyte proliferation system. Cellular and Molecular Biology Noisy le Grand 40:111-121.
239. Yordam N, Kandemir N, Topaloglu H et al (1994) Myositis associated with growth hormone therapy. Journal of Pediatrics 125:671.
240. Yoshida A, Ishioka C, Kimata H & Mikawa H (1992) Recombinant human growth hormone stimulates B-cell immunoglobulin synthesis and proliferation in serum-free medium. Acta Endocrinologica 126: 524-529.
241. Zimmer JA & Lipton JM (1981) Central and peripheral injections of ACTH (1-24) reduce fever in adrenalectomized rabbits. Peptides 2:413-417.